Clinical Professor John Gibson AM

Clinical Professor
Medicine, Central Clinical School
Bosch Institute

C39 - Royal Prince Alfred Hospital
The University of Sydney
NSW 2006 Australia

T: +61 2 9515 8031
F: +61 2 9515 8474


2014 | 2013 | 2012 | 2011 | 2010 | 2009


  • Favaloro, J., Brown, R., Aklilu, E., Yang, S., Suen, H., Hart, D., Fromm, P., Gibson, J., Khoo, L., Ho, P., Joshua, D. (2014), Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state. Leukemia & Lymphoma. 55(5), 1090-1098. [Abstract]
  • Favaloro, J., Liyadipitiya, T., Brown, R., Yang, S., Suen, H., Woodland, N., Nassif, N., Hart, D., Fromm, P., Weatherburn, C., Gibson, J., Ho, P., Joshua, D. (2014), Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma. Leukemia & Lymphoma. 55(12), 2893-2900. [Abstract]
  • Wright, C., Velickovic, Z., Brown, R., Larsen, S., Macpherson, J., Gibson, J., Rasko, J. (2014), Raising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products. Pathology. 46(3), 177-183. [Abstract]


  • Maziarz, R., Wang, Z., Zhang, M., Bolwell, B., Chen, A., Fenske, T., Freytes, C., Gale, R., Gibson, J., Hayes-Lattin, B., Holmberg, L., Inwards, D., Isola, L., Khoury, H., Lewis, V., Maharaj, D., Munker, R., Phillips, G., Rizzieri, D., Rowlings, P., Saber, W., Satwani, P., Waller, E., Maloney, D., Montoto, S., Laport, G., Vose, J., Lazarus, H., Hari, P. (2013), Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. British Journal of Haematology. 162(5), 648-656. [Abstract]
  • Thurtell, M., Chiu, A., Goold, L., Akdal, G., Crompton, J., Ahmed, R., Madge, S., Selva, D., Francis, I., Ghabrial, R., Ananda, A., Gibson, J., Chan, R., Thompson, E., Rodriguez, M., McCluskey, P., Halmagyi, G. (2013), Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature. Clinical & Experimental Ophthalmology. 41(6), 567-576. [Abstract]
  • Hamadani, M., Saber, W., Ahn, K., Carreras, J., Cairo, M., Fenske, T., Gale, R., Gibson, J., Hale, G., Hari, P., Hsu, J., Inwards, D., Kamble, R., Klein, A., Maharaj, D., Marks, D., Rizzieri, D., Savani, B., Schouten, H., Waller, E., Wirk, B., Laport, G., Montoto, S., Maloney, D., Lazarus, H. (2013), Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma. Biology of Blood and Marrow Transplantation. 19(5), 746-753. [Abstract]
  • Gibson, J., Iland, H., Larsen, S., Brown, C., Joshua, D. (2013), Leukaemias into the 21st century - part 2: the chronic leukaemias. Internal Medicine Journal. 43(5), 484-494. [Abstract]
  • Michaelis, L., Saad, A., Zhong, X., Le-Rademacher, J., Freytes, C., Marks, D., Lazarus, H., Bird, J., Holmberg, L., Kamble, R., Kumar, S., Lill, M., Meehan, K., Saber, W., Schriber, J., Tay, J., Vogl, D., Wirk, B., Savani, B., Gale, R., Vesole, D., Schiller, G., Abidi, M., Anderson, K., Nishihori, T., Kalaycio, M., Vose, J., Moreb, J., Drobyski, W., Munker, R., Roy, V., Ghobadi, A., Holland, H., Nath, R., To, L., Maiolino, A., Kassim, A., Giralt, S., Landau, H., Schouten, H., Maziarz, R., Michael, J., Kindwall-Keller, T., Stiff, P., Gibson, J., Lonial, S., Krishnan, A., Dispenzieri, A., Hari, P. (2013), Salvage second hematopoietic cell transplantation in myeloma. Biology of Blood and Marrow Transplantation. 19(5), 760-766. [Abstract]
  • Hamadani, M., Saber, W., Ahn, K., Carreras, J., Cairo, M., Fenske, T., Gale, R., Gibson, J., Hale, G., Hari, P., Hsu, J., Inwards, D., Kamble, R., Klein, A., Maharaj, D., Marks, D., Rizzieri, D., Savani, B., Schouten, H., Waller, E., Wirk, B., Lazarus, H. (2013), Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. Biology of Blood and Marrow Transplantation. 19(4), 625-631. [Abstract]
  • Ahmed, R., King, J., Gibson, J., Buckland, M., Gupta, R., Gonzales, M., Halmagyi, G. (2013), Spinal Leptomeningeal Lymphoma Presenting as Pseudotumor Syndrome. Journal of Neuro-ophthalmology. 33(1), 13-16. [Abstract]
  • Bryant, C., Suen, H., Brown, R., Yang, S., Favaloro, J., Aklilu, E., Gibson, J., Ho, P., Iland, H., Fromm, P., Woodland, N., Nassif, N., Hart, D., Joshua, D. (2013), Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance. Blood Cancer Journal. 3, e148. [Abstract]
  • Gasiorowski, R., Gibson, J., Watson, G., Trotman, J., Larsen, S. (2013), Rapidly fatal post-allogeneic stem cell transplant lymphoproliferative disorder presenting with skin and bone marrow involvement. Pathology. 45(1), 81-83. [Abstract]


  • Brown, R., Suen, H., Favaloro, J., Yang, S., Ho, P., Gibson, J., Joshua, D. (2012), Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma. Oncoimmunology. 1(9), 1658-1660. [Abstract]
  • Brown, C., Larsen, S., Iland, H., Joshua, D., Gibson, J. (2012), Leukaemias into the 21st century: part 1: the acute leukaemias. Internal Medicine Journal. 42(11), 1179-1186. [Abstract]
  • Ho, P., Brown, R., Spencer, A., Jeffels, M., Daniher, D., Gibson, J., Joshua, D. (2012), Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trial. Leukemia & Lymphoma. 53(9), 1728-1734. [Abstract]
  • Brown, R., Kabani, K., Favaloro, J., Yang, S., Ho, P., Gibson, J., Fromm, P., Suen, H., Woodland, N., Nassif, N., Hart, D., Joshua, D. (2012), CD86+ or HLA-G+ myeloma cells are associated with poor prognosis and once acquired by trogocytosis create novel Tregacq cells. Blood. 120(10), 2055-2063. [Abstract]
  • Chohan, G., Barnett, Y., Gibson, J., Reddel, S., Barnett, M. (2012), Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab. Journal of Neurology, Neurosurgery, and Psychiatry. 83(5), 573-575. [Abstract]


  • Vogl, D., Wang, T., PĂ©rez, W., Stadtmauer, E., Heitjan, D., Lazarus, H., Kyle, R., Kamble, R., Weisdorf, D., Roy, V., Gibson, J., Ballen, K., Holmberg, L., Bashey, A., McCarthy, P., Freytes, C., Maharaj, D., Maiolino, A., Vesole, D., Hari, P. (2011), Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. Biology of Blood and Marrow Transplantation. 17(12), 1765-1774. [Abstract]
  • Passweg, J., Zhang, M., Rocha, V., Kan, F., Champlin, R., Isola, L., Gee, A., Gibson, J., Laughlin, M., Lazarus, H., Loren, A., Marks, D., Gratwohl, A., Eapen, M. (2011), Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. Biology of Blood and Marrow Transplantation. 17(12), 1869-1873. [Abstract]
  • Nivison-Smith, I., Dodds, A., Doocey, R., Ganly, P., Gibson, J., Ma, D., Simpson, J., Szer, J., Bradstock, K. (2011), Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcome. Leukemia & Lymphoma. 52(9), 1727-1735. [Abstract]
  • Khoo, T., Vangsted, A., Joshua, D., Gibson, J. (2011), Interferon-alpha in the treatment of multiple myeloma. Current Drug Targets. 12(3), 437-446. [Abstract]
  • Brown, R., Langshaw, M., Uhr, E., Gibson, J., Joshua, D. (2011), The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian population. Medical Journal of Australia. 194(2), 65-67. [Abstract]


  • Suryani, S., Fulcher, D., Santner-Nanan, B., Nanan, R., Wong, M., Shaw, P., Gibson, J., Williams, A., Tangye, S. (2010), Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood. 115(3), 519-529. [Abstract]
  • Reece, D., Vesole, D., Shrestha, S., Zhang, M., Perez, W., Dispenzieri, A., Milone, G., Abidi, M., Atkins, H., Bashey, A., Bredeson, C., Boza, W., Freytes, C., Gale, R., Gajewski, J., Gibson, J., Hale, G., Kumar, S., Kyle, R., Lazarus, H., McCarthy, P., Paylovsky, S., Roy, V., Weisdorf, D., Wiernik, P., Hari, P. (2010), Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study. Clinical Lymphoma Myeloma & Leukemia. 10(6), 458-463. [Abstract]
  • Hari, P., Majhail, N., Zhang, M., Hassebroek, A., Siddiqui, F., Ballen, K., Bashey, A., Bird, J., Freytes, C., Gibson, J., Hale, G., Holmberg, L., Kamble, R., Kyle, R., Lazarus, H., LeMaistre, C., Loberiza, F., Maiolino, A., McCarthy, P., Milone, G., Omondi, N., Reece, D., Seftel, M., Trigg, M., Vesole, D., Weiss, B., Wiernik, P., Lee, S., Rizzo, J., Mehta, P. (2010), Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 16(3), 395-402. [Abstract]


  • Burgess, P., Robin, H., Langshaw, M., Kershaw, G., Pathiraja, R., Yuen, S., Coad, C., Xiros, N., Mansy, G., Coleman, R., Brown, R., Gibson, J., Holman, R., Hubbard, J., Wick, V., Lammers, M., Johnson, R., Huffman, K., Bell, J., Ibrahim, A., Estepa, F., Lovegrove, J., Joshua, D. (2009), Rule based processing of the CD4000, CD3200 and CD Sapphire analyser output using the Cerner Discern Expert Module. International journal of laboratory hematology. 31(0), 603-14. [Abstract]
  • Brown, R., Spencer, A., Ho, P., Kennedy, N., Kabani, K., Yang, S., Sze, D., Aklilu, E., Gibson, J., Joshua, D. (2009), Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma. Leukemia and Lymphoma. 50(11), 1860-1864. [Abstract]
  • Devetten, M., Hari, P., Carreras, J., Logan, B., van Besien, K., Bredeson, C., Freytes, C., Gale, R., Gibson, J., Giralt, S., Goldstein, S., Gupta, V., Marks, D., Maziorz, R., Vase, J., Lazarus, H., Anderlini, P. (2009), Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 15(1), 109-117. [Abstract]